Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 39.00 | |
5 mg | In stock | $ 91.00 | |
10 mg | In stock | $ 133.00 | |
25 mg | In stock | $ 263.00 | |
50 mg | In stock | $ 473.00 | |
100 mg | In stock | $ 693.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 159.00 |
Description | Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure. |
Targets&IC50 | PDE4A:21.1 μM (IC50, myocardial PDE4A), PDE3/PDE Ⅲ:5.9 μM (IC50) |
In vivo | Perioperative Enoximone administration improved renal function in patients undergoing on-pump cardiac surgery. |
Molecular Weight | 248.3 |
Formula | C12H12N2O2S |
CAS No. | 77671-31-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.48 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Enoximone 77671-31-9 Metabolism PDE inhibit bronchodilatory CD11b eosinophils vasodilating Phosphodiesterase (PDE) airway cAMP PDE3 PDE4A Inhibitor anti-inflammatory Antiasthma inhibitor